241 related articles for article (PubMed ID: 25466513)
1. Influence of socio-demographic features and apolipoprotein E epsilon 4 expression on the prevalence of dementia and cognitive impairment in a population of 70-74-year olds: the InveCe.Ab study.
Guaita A; Vaccaro R; Davin A; Colombo M; Vitali SF; Polito L; Abbondanza S; Valle E; Forloni G; Ferretti VV; Villani S
Arch Gerontol Geriatr; 2015; 60(2):334-43. PubMed ID: 25466513
[TBL] [Abstract][Full Text] [Related]
2. Apolipoprotein ɛ4 is Associated with Dementia and Cognitive Impairment Predominantly Due to Alzheimer's Disease and Not with Vascular Cognitive Impairment: A Singapore-Based Cohort.
Chai YL; Yeo HK; Wang J; Hilal S; Ikram MK; Venketasubramanian N; Wong BS; Chen CL
J Alzheimers Dis; 2016; 51(4):1111-8. PubMed ID: 26923016
[TBL] [Abstract][Full Text] [Related]
3. Five-Year Change in Body Mass Index Predicts Conversion to Mild Cognitive Impairment or Dementia Only in APOE ɛ4 Allele Carriers.
Kadey KR; Woodard JL; Moll AC; Nielson KA; Smith JC; Durgerian S; Rao SM
J Alzheimers Dis; 2021; 81(1):189-199. PubMed ID: 33749649
[TBL] [Abstract][Full Text] [Related]
4. C-reactive protein and rate of dementia in carriers and non carriers of Apolipoprotein APOE4 genotype.
Haan MN; Aiello AE; West NA; Jagust WJ
Neurobiol Aging; 2008 Dec; 29(12):1774-82. PubMed ID: 17540481
[TBL] [Abstract][Full Text] [Related]
5. Interaction between Apolipoprotein epsilon 4 and traumatic brain injury in patients with Alzheimer's disease and Mild Cognitive Impairment.
Mauri M; Sinforiani E; Bono G; Cittadella R; Quattrone A; Boller F; Nappi G
Funct Neurol; 2006; 21(4):223-8. PubMed ID: 17367583
[TBL] [Abstract][Full Text] [Related]
6. Predictive value of APOE-ε4 allele for progression from MCI to AD-type dementia: a meta-analysis.
Elias-Sonnenschein LS; Viechtbauer W; Ramakers IH; Verhey FR; Visser PJ
J Neurol Neurosurg Psychiatry; 2011 Oct; 82(10):1149-56. PubMed ID: 21493755
[TBL] [Abstract][Full Text] [Related]
7. Cognitive impairment without dementia in older people: prevalence, vascular risk factors, impact on disability. The Italian Longitudinal Study on Aging.
Di Carlo A; Baldereschi M; Amaducci L; Maggi S; Grigoletto F; Scarlato G; Inzitari D
J Am Geriatr Soc; 2000 Jul; 48(7):775-82. PubMed ID: 10894316
[TBL] [Abstract][Full Text] [Related]
8. Apolipoprotein E epsilon4 genotype as a risk factor for cognitive decline and dementia: data from the Canadian Study of Health and Aging.
Hsiung GY; Sadovnick AD; Feldman H
CMAJ; 2004 Oct; 171(8):863-7. PubMed ID: 15477624
[TBL] [Abstract][Full Text] [Related]
9. Association between Cerebrospinal Fluid Biomarkers for Alzheimer's Disease, APOE Genotypes and Auditory Verbal Learning Task in Subjective Cognitive Decline, Mild Cognitive Impairment, and Alzheimer's Disease.
Mandecka M; Budziszewska M; Barczak A; Pepłońska B; Chodakowska-Żebrowska M; Filipek-Gliszczyńska A; Nesteruk M; Styczyńska M; Barcikowska M; Gabryelewicz T
J Alzheimers Dis; 2016 Jul; 54(1):157-68. PubMed ID: 27472875
[TBL] [Abstract][Full Text] [Related]
10. Occurrence of cognitive impairment and dementia after the age of 60: a population-based study from Northern Italy.
De Ronchi D; Berardi D; Menchetti M; Ferrari G; Serretti A; Dalmonte E; Fratiglioni L
Dement Geriatr Cogn Disord; 2005; 19(2-3):97-105. PubMed ID: 15591799
[TBL] [Abstract][Full Text] [Related]
11. CIND and MCI in the Italian elderly: frequency, vascular risk factors, progression to dementia.
Di Carlo A; Lamassa M; Baldereschi M; Inzitari M; Scafato E; Farchi G; Inzitari D
Neurology; 2007 May; 68(22):1909-16. PubMed ID: 17536047
[TBL] [Abstract][Full Text] [Related]
12. Prevalence of dementia and cognitive impairment in Southeastern Spain: the Ariadna study.
Gavrila D; Antúnez C; Tormo MJ; Carles R; García Santos JM; Parrilla G; Fortuna L; Jiménez J; Salmerón D; Navarro C
Acta Neurol Scand; 2009 Nov; 120(5):300-7. PubMed ID: 19832772
[TBL] [Abstract][Full Text] [Related]
13. Risk factors for incident mild cognitive impairment--results from the German Study on Ageing, Cognition and Dementia in Primary Care Patients (AgeCoDe).
Luck T; Riedel-Heller SG; Luppa M; Wiese B; Wollny A; Wagner M; Bickel H; Weyerer S; Pentzek M; Haller F; Moesch E; Werle J; Eisele M; Maier W; van den Bussche H; Kaduszkiewicz H;
Acta Psychiatr Scand; 2010 Apr; 121(4):260-72. PubMed ID: 19824992
[TBL] [Abstract][Full Text] [Related]
14. Genome-wide significant risk factors for Alzheimer's disease: role in progression to dementia due to Alzheimer's disease among subjects with mild cognitive impairment.
Lacour A; Espinosa A; Louwersheimer E; Heilmann S; Hernández I; Wolfsgruber S; Fernández V; Wagner H; Rosende-Roca M; Mauleón A; Moreno-Grau S; Vargas L; Pijnenburg YA; Koene T; Rodríguez-Gómez O; Ortega G; Ruiz S; Holstege H; Sotolongo-Grau O; Kornhuber J; Peters O; Frölich L; Hüll M; Rüther E; Wiltfang J; Scherer M; Riedel-Heller S; Alegret M; Nöthen MM; Scheltens P; Wagner M; Tárraga L; Jessen F; Boada M; Maier W; van der Flier WM; Becker T; Ramirez A; Ruiz A
Mol Psychiatry; 2017 Jan; 22(1):153-160. PubMed ID: 26976043
[TBL] [Abstract][Full Text] [Related]
15. Prevalence and pattern of cognitive impairment in rural and urban populations from Northern Portugal.
Nunes B; Silva RD; Cruz VT; Roriz JM; Pais J; Silva MC
BMC Neurol; 2010 Jun; 10():42. PubMed ID: 20540726
[TBL] [Abstract][Full Text] [Related]
16. Risk factors for development of dementia in a unique six-year cohort study. I. An exploratory, pilot study of involvement of the E4 allele of apolipoprotein E, mutations of the hemochromatosis-HFE gene, type 2 diabetes, and stroke.
Percy M; Somerville MJ; Hicks M; Garcia A; Colelli T; Wright E; Kitaygorodsky J; Jiang A; Ho V; Parpia A; Wong MK
J Alzheimers Dis; 2014; 38(4):907-22. PubMed ID: 24081379
[TBL] [Abstract][Full Text] [Related]
17. Apolipoprotein E allele epsilon 4, dementia, and cognitive decline in a population sample.
Henderson AS; Easteal S; Jorm AF; Mackinnon AJ; Korten AE; Christensen H; Croft L; Jacomb PA
Lancet; 1995 Nov; 346(8987):1387-90. PubMed ID: 7475820
[TBL] [Abstract][Full Text] [Related]
18. Risk factors for transitions from normal to mild cognitive impairment and dementia.
Kryscio RJ; Schmitt FA; Salazar JC; Mendiondo MS; Markesbery WR
Neurology; 2006 Mar; 66(6):828-32. PubMed ID: 16567698
[TBL] [Abstract][Full Text] [Related]
19. Prevalence and distribution of cognitive impairment no dementia (CIND) among the aged population and the analysis of socio-demographic characteristics: the community-based cross-sectional study.
Fei M; Qu YC; Wang T; Yin J; Bai JX; Ding QH
Alzheimer Dis Assoc Disord; 2009; 23(2):130-8. PubMed ID: 19474570
[TBL] [Abstract][Full Text] [Related]
20. Mild cognitive impairment: epidemiology and dementia risk in an elderly Italian population.
Ravaglia G; Forti P; Montesi F; Lucicesare A; Pisacane N; Rietti E; Dalmonte E; Bianchin M; Mecocci P
J Am Geriatr Soc; 2008 Jan; 56(1):51-8. PubMed ID: 18028343
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
